Phase II 'Proof of Concept' Trial Evaluating Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab in Combination With Chemotherapy in Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 May 2017
At a glance
- Drugs Bevacizumab (Primary) ; Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil; Trastuzumab
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms AVASTEM
- 07 Jun 2017 Biomarkers information updated
- 19 Mar 2013 Planned end date changed from 1 May 2018 to 1 May 2017 as reported by ClinicalTrials.gov.
- 19 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.